Search Tag: O3® Regional Oximetr

ICU Management

FDA Clearance for Masimo O3® Regional Oximetry for Extended Use in Cerebral & Somatic Applications

2020 31 Aug

Masimo  today announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic... Read more